Literature DB >> 26977028

Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.

Shuai Shao1, Ping-Hui Sun1, Lucy K Satherley1, Xiangyu Gao2, K E Ji1, Y I Feng1, Yongning Jia3, Jiafu Ji3, Wen G Jiang1, Lin Ye4.   

Abstract

AIM: Ran binding protein M (RanBPM) is a ubiquitous, nucleocytoplasmic protein that serves as a scaffolding molecule. This study aimed to investigate the role of RanBPM in gastric cancer.
MATERIALS AND METHODS: RanBPM expression in human gastric cancer tissue samples was analyzed using real-time polymerase chain reaction. The effect of RanBPM on cellular functions was examined in RanBPM-knockdown gastric cells and with in vitro cell functional assays.
RESULTS: Gastric tumors with distant metastases expressed lower levels of RanBPM transcripts compared to tumours without detectable metastases (p=0.036). RanBPM knockdown in gastric cancer cells reduced adhesion and promoted survival of gastric cancer cells after exposure to methotrexate and fluorouracil.
CONCLUSION: RanBPM levels were reduced in gastric tumors with distant metastases. This suggests that loss of RanBPM expression may play an important role in gastric cancer tumor development and metastasis. Reduced RanBPM expression is also associated with chemoresistance of gastric cancer cells. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  RanBPM; gastric cancer; growth; invasion; matrix metalloproteinase; migration

Mesh:

Substances:

Year:  2016        PMID: 26977028

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Cell signalling pathway regulation by RanBPM: molecular insights and disease implications.

Authors:  Louisa M Salemi; Matthew E R Maitland; Christina J McTavish; Caroline Schild-Poulter
Journal:  Open Biol       Date:  2017-06       Impact factor: 6.411

2.  Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.

Authors:  Louisa M Salemi; Matthew E R Maitland; Eyal R Yefet; Caroline Schild-Poulter
Journal:  BMC Cancer       Date:  2017-07-01       Impact factor: 4.430

Review 3.  The CTLH Complex in Cancer Cell Plasticity.

Authors:  Nickelas Huffman; Dario Palmieri; Vincenzo Coppola
Journal:  J Oncol       Date:  2019-11-30       Impact factor: 4.375

4.  Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Guangbin Wu; Ji Li; Chunzhi Qin
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.